Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy

• Status: Completed
• Trial end date: 2014-07-01

Summary

To evaluate the long term effectiveness of Levetiracetam (LEV) monotherapy on Treatment Failure Rate in subjects with newly diagnosed partial onset seizures with or without secondary generalized seizures, compared to Oxcarbazepine (OXC) monotherapy over 50 weeks from the first dose

• Phase: Phase 4

Details

• Lead Sponsor: Korea UCB Co., Ltd.
• Treatments: Carbamazepine; Etiracetam; Levetiracetam; Oxcarbazepine; Piracetam